Final Program Introduction of CVRF
| Date | Time | Place | Session / Title | Role |
| April 29 | 9:40 AM - 10:30 AM | Endovascular Theater, Level 1 | Endovascular Session I. Changing Paradigm and Future Concepts in Peripheral Intervention: Iliac to SFA | Moderator |
| April 29 | 9:48 AM - 9:56 AM | Endovascular Theater, Level 1 | Endovascular Session I. Changing Paradigm and Future Concepts in Peripheral Intervention: Iliac to SFA First in Human Results of the Selution Sirolimus Drug Coated Balloon in Femoral-Popliteal Disease |
Lecturer |
| April 29 | 10:30 AM - 11:30 AM | Endovascular Theater, Level 1 | Live Case Session II | Moderator |
| April 29 | 3:00 PM - 3:08 PM | Endovascular Theater, Level 1 | Endovascular Session III. Aorta New Technologies and Techniques to Deal with Adverse AAA Neck Anatomy |
Lecturer |
| April 29 | 4:00 PM - 5:00 PM | Asan Medical Center, Seoul, Korea | Live Case Session IV Asan Medical Center, Seoul, Korea: Case #7 |
1st Operator |
| April 30 | 10:30 AM - 12:30 PM | Valve Theater, Level 1 | TCTAP Endovascular Symposium | Moderator |
| April 30 | 12:01 PM - 12:09 PM | Valve Theater, Level 1 | TCTAP Endovascular Symposium Renal Artery Stenosis: Nothing to Do? |
Lecturer |
| April 30 | 2:00 PM - 4:00 PM | Valve Theater, Level 1 | Live Case & Lecture Session I | Discussant |
| April 30 | 4:56 PM - 5:51 PM | Room 104, Level 1 | TCTAP 2018 - Featured Clinical Research from Abstracts | Panelist |
| April 30 | 5:36 PM - 5:40 PM | Room 104, Level 1 | TCTAP 2018 - Featured Clinical Research from Abstracts Discussion: Survival and Adverse Events in Patients with Acute Type B Aortic Dissection Who Received Endovascular Therapy or Medical Management Alone: A Population-based Cohort Study |
Discussant |
| May 01 | 10:30 AM - 11:30 AM | Room 104, Level 1 | Complex Valve Intervention: AV | Panelist |
